Journal
CELL CYCLE
Volume 9, Issue 6, Pages 1097-1103Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.9.6.11046
Keywords
circadian; hematopoietic system; breast cancer; prostate cancer; tumorigenesis
Categories
Funding
- NCI NIH HHS [R01 CA026038, R01 CA026038-32, R01 CA026038-31, R01 CA026038-30A2] Funding Source: Medline
Ask authors/readers for more resources
The circadian clock is an endogenous time keeping system shared by most organisms. In mammals, a master pacemaker in the hypothalamus orchestrates temporal alignment of behavior and physiology by transmitting daily signals to multiple clocks in peripheral tissues. Disruption of this communication has a profound affect on human health and has been linked to diverse pathogenic conditions, including cancer. At the center of the molecular circadian machinery is a set of clock genes, generating rhythmic oscillations on a cellular level. In the past several years, research from different fields has revealed the complexity and ubiquitous nature of circadian regulation, uncovering intriguing associations between clock components and cellular pathways implicated in tumorigenesis. In this review, we discuss the emerging role of circadian genes in hematological and hormone-related malignances. These new insights suggest that manipulating circadian biology as a way to fight cancer, as well as, other life threatening diseases is within the realm of possibility.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available